IL-33 markedly activates murine eosinophils by an NF-κB-dependent mechanism differentially dependent upon an IL-4-driven autoinflammatory loop

Journal of Immunology

Volumn 191, Issue 8, 2013, Pages 4317-4325

  Bouffi, Carine ^a   Rochman, Mark ^a   Zust, Christopher B ^a   Stucke, Emily M ^a   Kartashov, Andrey ^a   Fulkerson, Patricia C ^a   Barski, Artem ^a   Rothenberg, Marc E ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 33; INTERLEUKIN 4; STAT6 PROTEIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSCRIPTOME;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CCL17 GENE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; GENE; GENE EXPRESSION; GENETIC REGULATION; LEUKOCYTE ACTIVATION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; RETNLA GENE; RNA SEQUENCE; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES; BASE SEQUENCE; BONE MARROW CELLS; CELLS, CULTURED; EOSINOPHILS; INFLAMMATION; INTERLEUKIN-4; INTERLEUKINS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NF-KAPPA B; PHOSPHORYLATION; RECEPTORS, INTERLEUKIN-4; SEQUENCE ANALYSIS, RNA; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR;

EID: 84885456137     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301465     Document Type: Article

References (55)

1. Funakoshi-Tago, M., K. Tago, M. Hayakawa, S. Tominaga, T. Ohshio, Y. Sonoda, and T. Kasahara. 2008. TRAF6 is a critical signal transducer in IL-33 signaling pathway. Cell. Signal. 20: 1679-1686.
2. Schmitz, J., A. Owyang, E. Oldham, Y. Song, E. Murphy, T. K. McClanahan, G. Zurawski, M. Moshrefi, J. Qin, X. Li, et al. 2005. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-Associated cytokines. Immunity 23: 479-490.
3. Allakhverdi, Z., D. E. Smith, M. R. Comeau, and G. Delespesse. 2007. Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J. Immunol. 179: 2051-2054.
4. Pecaric-Petkovic, T., S. A. Didichenko, S. Kaempfer, N. Spiegl, and C. A. Dahinden. 2009. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 113: 1526-1534.
5. Kurowska-Stolarska, M., B. Stolarski, P. Kewin, G. Murphy, C. J. Corrigan, S. Ying, N. Pitman, A. Mirchandani, B. Rana, N. van Rooijen, et al. 2009. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J. Immunol. 183: 6469-6477.
6. Liew, F. Y., N. I. Pitman, and I. B. McInnes. 2010. Disease-Associated functions of IL-33: the new kid in the IL-1 family. Nat. Rev. Immunol. 10: 103-110.
7. Préfontaine, D., S. Lajoie-Kadoch, S. Foley, S. Audusseau, R. Olivenstein, A. J. Halayko, C. Lemière, J. G. Martin, and Q. Hamid. 2009. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J. Immunol. 183: 5094-5103.
8. Préfontaine, D., J. Nadigel, F. Chouiali, S. Audusseau, A. Semlali, J. Chakir, J. G. Martin, and Q. Hamid. 2010. Increased IL-33 expression by epithelial cells in bronchial asthma. J. Allergy Clin. Immunol. 125: 752-754.
9. Stolarski, B., M. Kurowska-Stolarska, P. Kewin, D. Xu, and F. Y. Liew. 2010. IL-33 exacerbates eosinophil-mediated airway inflammation. J. Immunol. 185: 3472-3480.
10. Rothenberg, M. E., and S. P. Hogan. 2006. The eosinophil. Annu. Rev. Immunol. 24: 147-174.
11. Hoshino, M., Y. Nakamura, J. Sim, J. Shimojo, and S. Isogai. 1998. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J. Allergy Clin. Immunol. 102: 783-788.
12. Hoshino, M., M. Takahashi, and N. Aoike. 2001. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J. Allergy Clin. Immunol. 107: 295-301.
13. Levi-Schaffer, F., E. Garbuzenko, A. Rubin, R. Reich, D. Pickholz, P. Gillery, H. Emonard, A. Nagler, and F. A. Maquart. 1999. Human eosinophils regulate human lung-And skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta). Proc. Natl. Acad. Sci. USA 96: 9660-9665.
14. Kita, H., T. Ohnishi, Y. Okubo, D. Weiler, J. S. Abrams, and G. J. Gleich. 1991. Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J. Exp. Med. 174: 745-748.
15. Lopez, A. F., C. G. Begley, D. J. Williamson, D. J. Warren, M. A. Vadas, and C. J. Sanderson. 1986. Murine eosinophil differentiation factor: an eosinophilspecific colony-stimulating factor with activity for human cells. J. Exp. Med. 163: 1085-1099.
16. Shinkai, K., M. Mohrs, and R. M. Locksley. 2002. Helper T cells regulate type-2 innate immunity in vivo. Nature 420: 825-829.
17. Voehringer, D., K. Shinkai, and R. M. Locksley. 2004. Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity 20: 267-277.
18. Wu, D., A. B. Molofsky, H. E. Liang, R. R. Ricardo-Gonzalez, H. A. Jouihan, J. K. Bando, A. Chawla, and R. M. Locksley. 2011. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 332: 243-247.
19. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261.
20. Li, L., Y. Xia, A. Nguyen, L. Feng, and D. Lo. 1998. Th2-induced eotaxin expression and eosinophilia coexist with Th1 responses at the effector stage of lung inflammation. J. Immunol. 161: 3128-3135.
21. Chatila, T. A. 2004. Interleukin-4 receptor signaling pathways in asthma pathogenesis. Trends Mol. Med. 10: 493-499.
22. Andrews, A. L., J. W. Holloway, S. T. Holgate, and D. E. Davies. 2006. IL-4 receptor alpha is an important modulator of IL-4 and IL-13 receptor binding: implications for the development of therapeutic targets. J. Immunol. 176: 7456-7461.
23. Kaplan, M. H., U. Schindler, S. T. Smiley, and M. J. Grusby. 1996. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4: 313-319.
24. Perkins, C., M. Wills-Karp, and F. D. Finkelman. 2006. IL-4 induces IL-13-independent allergic airway inflammation. J. Allergy Clin. Immunol. 118: 410-419.
25. Munitz, A., E. B. Brandt, M. Mingler, F. D. Finkelman, and M. E. Rothenberg. 2008. Distinct roles for IL-13 and IL-4 via IL-13 receptor alpha1 and the type II IL-4 receptor in asthma pathogenesis. Proc. Natl. Acad. Sci. USA 105: 7240-7245.
26. Dyer, K. D., J. M. Moser, M. Czapiga, S. J. Siegel, C. M. Percopo, and H. F. Rosenberg. 2008. Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow. J. Immunol. 181: 4004-4009.
27. Trapnell, C., A. Roberts, L. Goff, G. Pertea, D. Kim, D. R. Kelley, H. Pimentel, S. L. Salzberg, J. L. Rinn, and L. Pachter. 2012. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7: 562-578.
28. de Hoon, M. J., S. Imoto, J. Nolan, and S. Miyano. 2004. Open source clustering software. Bioinformatics 20: 1453-1454.
29. Saldanha, A. J. 2004. Java Treeview-extensible visualization of microarray data. Bioinformatics 20: 3246-3248.
30. Matsuba-Kitamura, S., T. Yoshimoto, K. Yasuda, S. Futatsugi-Yumikura, Y. Taki, T. Muto, T. Ikeda, O. Mimura, and K. Nakanishi. 2010. Contribution of IL-33 to induction and augmentation of experimental allergic conjunctivitis. Int. Immunol. 22: 479-489.
31. Suzukawa, M., R. Koketsu, M. Iikura, S. Nakae, K. Matsumoto, H. Nagase, H. Saito, K. Matsushima, K. Ohta, K. Yamamoto, and M. Yamaguchi. 2008. Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils. Lab. Invest. 88: 1245-1253.
32. Schleimer, R. P., S. A. Sterbinsky, J. Kaiser, C. A. Bickel, D. A. Klunk, K. Tomioka, W. Newman, F. W. Luscinskas, M. A. Gimbrone, Jr., B.W. McIntyre, et al. 1992. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: association with expression of VCAM-1. J. Immunol. 148: 1086-1092.
33. Heller, N. M., W. M. Gwinn, R. P. Donnelly, S. L. Constant, and A. D. Keegan. 2012. IL-4 engagement of the type I IL-4 receptor complex enhances mouse eosinophil migration to eotaxin-1 in vitro. PLoS One 7: e39673.
34. Rehli, M., S. Sulzbacher, S. Pape, T. Ravasi, C. A. Wells, S. Heinz, L. Söllner, C. El Chartouni, S. W. Krause, E. Steingrimsson, et al. 2005. Transcription factor Tfec contributes to the IL-4-inducible expression of a small group of genes in mouse macrophages including the granulocyte colony-stimulating factor receptor. J. Immunol. 174: 7111-7122.
35. Doherty, T. A., N. Khorram, K. Sugimoto, D. Sheppard, P. Rosenthal, J. Y. Cho, A. Pham, M. Miller, M. Croft, and D. H. Broide. 2012. Alternaria induces STAT6-dependent acute airway eosinophilia and epithelial FIZZ1 expression that promotes airway fibrosis and epithelial thickness. J. Immunol. 188: 2622-2629.
36. Wen, T., M. K. Mingler, C. Blanchard, B. Wahl, O. Pabst, and M. E. Rothenberg. 2012. The pan-B cell marker CD22 is expressed on gastrointestinal eosinophils and negatively regulates tissue eosinophilia. J. Immunol. 188: 1075-1082.
37. Piehler, D., W. Stenzel, A. Grahnert, J. Held, L. Richter, G. Köhler, T. Richter, M. Eschke, G. Alber, and U. Müller. 2011. Eosinophils contribute to IL-4 production and shape the T-helper cytokine profile and inflammatory response in pulmonary cryptococcosis. Am. J. Pathol. 179: 733-744.
38. Munitz, A., A. Waddell, L. Seidu, E. T. Cole, R. Ahrens, S. P. Hogan, and M. E. Rothenberg. 2008. Resistin-like molecule alpha enhances myeloid cell activation and promotes colitis. J. Allergy Clin. Immunol. 122: 1200-1207.e1.
39. Melo, R. C., L. A. Spencer, S. A. Perez, I. Ghiran, A. M. Dvorak, and P. F. Weller. 2005. Human eosinophils secrete preformed, granule-stored interleukin-4 through distinct vesicular compartments. Traffic 6: 1047-1057.
40. Spencer, L. A., R. C. Melo, S. A. Perez, S. P. Bafford, A. M. Dvorak, and P. F. Weller. 2006. Cytokine receptor-mediated trafficking of preformed IL-4 in eosinophils identifies an innate immune mechanism of cytokine secretion. Proc. Natl. Acad. Sci. USA 103: 3333-3338.
41. Suzukawa, M., M. Iikura, R. Koketsu, H. Nagase, C. Tamura, A. Komiya, S. Nakae, K. Matsushima, K. Ohta, K. Yamamoto, and M. Yamaguchi. 2008. An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. J. Immunol. 181: 5981-5989.
42. Pushparaj, P. N., D. Li, M. Komai-Koma, R. Guabiraba, J. Alexander, C. McSharry, and D. Xu. 2013. Interleukin-33 exacerbates acute colitis via interleukin-4 in mice. Immunology 140: 70-77.
43. Komai-Koma, M., F. Brombacher, P. N. Pushparaj, B. Arendse, C. McSharry, J. Alexander, R. Chaudhuri, N. C. Thomson, A. N. McKenzie, I. McInnes, et al. 2012. Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naive mice. Allergy 67: 1118-1126.
44. Humphreys, N. E., D. Xu, M. R. Hepworth, F. Y. Liew, and R. K. Grencis. 2008. IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J. Immunol. 180: 2443-2449.
45. Goh, Y. P., N. C. Henderson, J. E. Heredia, A. Red Eagle, J. I. Odegaard, N. Lehwald, K. D. Nguyen, D. Sheppard, L. Mukundan, R. M. Locksley, and A. Chawla. 2013. Eosinophils secrete IL-4 to facilitate liver regeneration. Proc. Natl. Acad. Sci. USA 110: 9914-9919.
46. Heredia, J. E., L. Mukundan, F. M. Chen, A. A. Mueller, R. C. Deo, R. M. Locksley, T. A. Rando, and A. Chawla. 2013. Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell 153: 376-388.
47. Miller, A. M., D. L. Asquith, A. J. Hueber, L. A. Anderson, W. M. Holmes, A. N. McKenzie, D. Xu, N. Sattar, I. B. McInnes, and F. Y. Liew. 2010. Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circ. Res. 107: 650-658.
48. Wang, H. B., and P. F. Weller. 2008. Pivotal advance: eosinophils mediate early alum adjuvant-elicited B cell priming and IgM production. J. Leukoc. Biol. 83: 817-821.
49. McKee, A. S., M. W. Munks, M. K. MacLeod, C. J. Fleenor, N. Van Rooijen, J. W. Kappler, and P. Marrack. 2009. Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity. J. Immunol. 183: 4403-4414.
50. Voehringer, D., T. A. Reese, X. Huang, K. Shinkai, and R. M. Locksley. 2006. Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic noneosinophil cells of the innate immune system. J. Exp. Med. 203: 1435-1446.
51. Dong, L., S. J. Wang, B. Camoretti-Mercado, H. J. Li, M. Chen, and W. X. Bi. 2008. FIZZ1 plays a crucial role in early stage airway remodeling of OVAinduced asthma. J. Asthma 45: 648-653.
52. Liu, T., S. M. Dhanasekaran, H. Jin, B. Hu, S. A. Tomlins, A. M. Chinnaiyan, and S. H. Phan. 2004. FIZZ1 stimulation of myofibroblast differentiation. Am. J. Pathol. 164: 1315-1326.
53. Munitz, A., L. Seidu, E. T. Cole, R. Ahrens, S. P. Hogan, and M. E. Rothenberg. 2009. Resistin-like molecule alpha decreases glucose tolerance during intestinal inflammation. J. Immunol. 182: 2357-2363.
54. Cherry, W. B., J. Yoon, K. R. Bartemes, K. Iijima, and H. Kita. 2008. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J. Allergy Clin. Immunol. 121: 1484-1490.
55. Chow, J. Y., C. K. Wong, P. F. Cheung, and C. W. Lam. 2010. Intracellular signaling mechanisms regulating the activation of human eosinophils by the novel Th2 cytokine IL-33: implications for allergic inflammation. Cell. Mol. Immunol. 7: 26-34.